Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Weight Loss Breaks the Bond Between Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: A Clinical and Epidemiological Perspective Publisher Pubmed



Ala M1 ; Eftekhar SP2
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran
  2. 2. Student Research Committee, Health Research Center, Babol University of Medical Sciences, Babol, Iran

Source: Obesity Reviews Published:2023


Abstract

Nonalcoholic fatty liver disease (NAFLD) is a growing health concern that is closely related to obesity and metabolic syndrome. In particular, NAFLD has been increasingly reported in adolescents and young adults in recent years. Cardiovascular diseases (CVDs) such as cardiac remodeling, heart failure, myocardial infarction, valvular heart diseases, and arrhythmia are more common in patients with NAFLD. CVD are the major cause of mortality in NAFLD. Although NAFLD often affects patients with obesity/overweight, it can also affect subjects with normal body mass index (BMI), known as lean NAFLD, which has a strong correlation with CVD. Obesity imposes a considerably increased risk of NAFLD and CVD. Consistently, weight-lowering approaches that can pronouncedly decrease body weight and maintain it in the long term, such as bariatric surgery and treatment with semaglutide and tirzepatide, have been promising in alleviating both CVD and NAFLD. Interestingly, compared with patients with NAFLD and obesity, a minimal amount of weight loss resolves NAFLD in lean patients. Besides the widespread use of bariatric surgery, the development of new GLP-1 agonists and GLP-1 GIP agonists revolutionized the treatment of obesity in recent years. Here, we discuss the interwoven correlation between obesity, NAFLD, and CVD and the benefits of weight-lowering approaches. © 2023 World Obesity Federation.
Related Docs
View other Related Docs
1. The Pathophysiological Associations Between Obesity, Nafld, and Atherosclerotic Cardiovascular Diseases, Hormone and Metabolic Research (2024)
2. The Effects of Subcutaneous Tirzepatide on Obesity and Overweight: A Systematic Review and Meta‐Regression Analysis of Randomized Controlled Trials, Frontiers in Endocrinology (2023)
3. Lean Individual's Non-Alcoholic Fatty Liver Disease: A Review Article; [بیماري کبد چرب غیرالکلی در افراد لاغر: یک مقاله مروري], Tehran University Medical Journal (2022)
4. Advancing the Global Public Health Agenda for Nafld: A Consensus Statement, Nature Reviews Gastroenterology and Hepatology (2022)
5. Benefits and Harms of Drug Treatment for Type 2 Diabetes: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials, BMJ (2023)
6. Emerging Role of Nanotechnology in Treatment of Non-Alcoholic Fatty Liver Disease (Nafld), EXCLI Journal (2023)
7. A Randomized Triple-Blind Controlled Clinical Trial Evaluation of Sitagliptin in the Treatment of Patients With Non-Alcoholic Fatty Liver Diseases Without Diabetes, Frontiers in Medicine (2022)
8. Assessment of Genetic Aspects of Non-Alcoholic Fatty Liver and Premature Cardiovascular Events, Middle East Journal of Digestive Diseases (2020)
Experts (# of related papers)
View all Related Experts
Hossein Poustchi (12)
Khadijeh Mirzaei (9)
Other Related Docs
9. Polypill for Prevention of Cardiovascular Diseases With Focus on Non-Alcoholic Steatohepatitis: The Polyiran-Liver Trial, European Heart Journal (2022)
10. The Association Between Nonalcoholic Fatty Liver Disease and Corrected Qt Interval Prolongation Among Generally Healthy Iranian Population: Fasa Cohort Study (Facs), Clinical Cardiology (2023)
11. Fibrosis Score 4 Index Has an Independent Relationship With Coronary Artery Diseases in Patients With Metabolic-Associated Fatty Liver Disease, Diabetology and Metabolic Syndrome (2023)
12. Metabolic Phenotypes of Obese, Overweight, and Normal Weight Individuals and Risk of Chronic Kidney Disease: A Systematic Review and Meta-Analysis, Archives of Endocrinology and Metabolism (2019)
13. Assessment of Lean Patients With Non-Alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association With Metabolic Disorders: A Cross-Sectional Study, Archives of Iranian Medicine (2017)
14. Visceral Adipose Tissue and Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes, Digestive Diseases and Sciences (2022)
15. Exploring Metabolically Healthy Obesity: Prevalence, Characteristics, and Cardiovascular Risk in the Iranian Population Based on the Steps 2021, Journal of Diabetes and Metabolic Disorders (2023)
16. The Clinical Value of Metabolic Syndrome and Its Components With Respect to Sudden Cardiac Death Using Different Definitions: Two Decades of Follow-Up From the Tehran Lipid and Glucose Study, Cardiovascular Diabetology (2022)
17. The Interaction Between Dietary Total Antioxidant Capacity and Mc4r Gene and Homa-Ir in Metabolically Healthy and Unhealthy Overweight and Obese Women, Nutrition and Metabolic Insights (2022)
18. The Effects of Smoking on Metabolic Syndrome and Its Components Using Causal Methods in the Iranian Population, International Journal of Preventive Medicine (2021)
19. The Effects of Weight Loss Interventions on Children and Adolescents With Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis, Obesity Science and Practice (2024)
20. Sodium Status and the Metabolic Syndrome: A Systematic Review and Meta-Analysis of Observational Studies, Critical Reviews in Food Science and Nutrition (2019)
21. Dietary Intakes of Flavonoids and Carotenoids and the Risk of Developing an Unhealthy Metabolic Phenotype, Food and Function (2020)
22. Relationships Between the Intake of Milk Fat Percentage and Cardio-Metabolic Indices in Adult Men: Results From a Cross-Sectional Study, Iranian Journal of Nutrition Sciences and Food Technology (2024)
23. Effects of Naringenin Supplementation in Overweight/Obese Patients With Non-Alcoholic Fatty Liver Disease: Study Protocol for a Randomized Double-Blind Clinical Trial, Trials (2021)
24. Variations in Serum Free Thyroxine Concentration Within the Reference Range Predicts the Incidence of Metabolic Syndrome in Non-Obese Adults: A Cohort Study, Thyroid (2017)
25. Distribution of Body Mass Index in Children With Different Parental Risk: Findings of a Family-Based Cohort Study in a West-Asian Population, Scientific Reports (2019)
26. The Effect of Smoking on Latent Hazard Classes of Metabolic Syndrome Using Latent Class Causal Analysis Method in the Iranian Population, BMC Public Health (2023)
27. Association of Plant-Based Diets With Adropin, Atherogenic Index of Plasma, and Metabolic Syndrome and Its Components: A Cross-Sectional Study on Adults, Frontiers in Nutrition (2023)
28. Obstructive Sleep Apnea and Severity of Coronary Artery Disease, Caspian Journal of Internal Medicine (2018)
29. The Interaction Between Cry1 Polymorphism and Alternative Healthy Eating Index (Ahei) on Cardiovascular Risk Factors in Overweight Women and Women With Obesity: A Cross-Sectional Study, BMC Endocrine Disorders (2023)
30. Prevalence of Vitamin D Deficiency and Its Association With Metabolic Syndrome Among the Elderly Population of Birjand, Iran, Journal of Diabetes and Metabolic Disorders (2022)
31. Effects of Pistachios on Glycaemic Control: A Systematic Review and Meta-Analysis of Randomised Controlled Trials, British Journal of Nutrition (2023)
32. The Effects of Cpap Therapy on Metabolic Profile and Subjective Sleep Parameters in Patients With Osa: A Prospective Trial Study, Sleep Science (2022)
33. A Nationwide Study of Metabolic Syndrome Prevalence in Iran; a Comparative Analysis of Six Definitions, PLoS ONE (2021)
34. The Risk of Metabolic Syndrome in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis, Clinical Endocrinology (2018)
35. The Association Between Dietary Diversity Score and Odds of Nonalcoholic Fatty Liver Disease: A Case-Control Study, European Journal of Gastroenterology and Hepatology (2022)
36. Determinants of Incident Prediabetes and Type 2 Diabetes in a 7-Year Cohort in a Developing Country: The Isfahan Cohort Study, Journal of Diabetes (2015)
37. Early Postpartum Glucose Intolerance, Metabolic Syndrome and Gestational Diabetes Mellitus Determinants After Assisted Conception: A Prospective Cohort Study, International Journal of Fertility and Sterility (2022)
38. Prevalence of Metabolic Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-Analysis, Iranian Red Crescent Medical Journal (2015)
39. Risk of Type 2 Diabetes in Metabolically Healthy People in Different Categories of Body Mass Index: An Updated Network Meta-Analysis of Prospective Cohort Studies, Journal of Cardiovascular and Thoracic Research (2019)
40. The Joint Association of Serum Vitamin D Status and Cardiorespiratory Fitness With Obesity and Metabolic Syndrome in Tehranian Adults, British Journal of Nutrition (2022)
41. Population-Based Pattern of Medication Use and Prevalence of Polypharmacy Among Patients With Cardiovascular Diseases: Results of the Pars Cohort Study From Iran, BMC Cardiovascular Disorders (2022)
42. Longitudinal Association Between Body Mass Index and Physical Activity Among Adolescents With Different Parental Risk: A Parallel Latent Growth Curve Modeling Approach, International Journal of Behavioral Nutrition and Physical Activity (2020)
43. Sex Specific Impact of Different Obesity Phenotypes on the Risk of Incident Hypertension: Tehran Lipid and Glucose Study, Nutrition and Metabolism (2019)
44. Association of Nightly Fasting Duration, Meal Timing and Frequency With the Metabolic Syndrome Among Iranian Adults, British Journal of Nutrition (2023)
45. The Association of Dietary Inflammatory Index (Dii) and Central Obesity With Non-Alcoholic Fatty Liver Disease (Nafld) in People With Diabetes (T2dm), Heliyon (2023)
46. Abdominal Obesity Phenotypes and Incident Diabetes Over 12 Years of Follow-Up: The Tehran Lipid and Glucose Study, Diabetes Research and Clinical Practice (2018)
47. Prediction of Adverse Pregnancy Outcomes by First-Trimester Components of Metabolic Syndrome: A Prospective Longitudinal Study, Archives of Gynecology and Obstetrics (2023)
48. Role of Dietary Approaches to Stop Hypertension Diet in Risk of Metabolic Syndrome: Evidence From Observational and Interventional Studies, International Journal of Preventive Medicine (2021)
49. Does Metabolic Syndrome Increase the Risk of Fracture? a Systematic Review and Meta-Analysis, Archives of Osteoporosis (2022)
50. The Association Between Consumption of Red and Processed Meats With Metabolic Syndrome and Its Components in Obese and Overweight Women: A Cross-Sectional Study, BMC Women's Health (2024)